topical formulations

Integrated pharmaceutical organisation Encube Ethicals has opened a new high potency manufacturing facility for topical formulations, the company has announced. Read more


Hovione has announced the launch of its Phase I clinical trial of its minocycline sterile ointment, HY02, for the treatment of a subset of ocular surface inflammation. Read more


Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, has reinforced its early stage topical and semi-solids capability by investing in a Becomix homogeniser mixer Read more


Glenn Saldanha, chairman & managing director, Glenmark

Glenmark Pharmaceuticals

The facility will be spread over 100,000 sq. ft (around 15 acre plot) and the company will first begin work on an oral solid unit and thereafter set up manufacturing units for injectables and topicals. Read more

Encube Ethicals, a pharmaceutical CDMO focussing on dermatology and semisolid manufacturing from its facility located in Goa, India, has been proudly associated with CPhi Worldwide/ICSE for the past three years. Read more